The urinary metabolomics profile of an Italian autistic children population and their unaffected siblings

NOTO, ANTONIO;FANOS, VASSILIOS;BARBERINI, LUIGI;Grapov, D;FATTUONI, CLAUDIA;Zaffanello, M;CASANOVA, ANDREA;FENU, GIANNI;De Giacomo, A;De Angelis, M;Moretti, C;Papoff, P;Ditonno, R;Francavilla, R.

2014-01-01

---

Abstract

Objective: A supervised multivariate model to classify the metabolome alterations between autistic spectrum disorders (ASD) patients and controls, siblings of autistic patients, has been realized and used to realize a network model of the ASD patients’ metabolome. Methods: In our experiment we propose a quantification of urinary metabolites with the Mass Spectroscopy technique couple to Gas Chromatography. A multivariate model has been used to extrapolate the variables of importance for a network model of interaction between metabolites. In this way we are able to propose a network-based approach to ASD description. Results: Children with autistic disease composing our studied population showed elevated concentration of several organic acids and sugars. Interactions among diet, intestinal flora and genes may explain such findings. Among them, the 3-(3-hydroxyphenyl)-3-hydroxypropanoic acid has been previously described as altered in autistic subjects. Other metabolites increased are 3,4-dihydroxybutyric acid, glycolic acid and glycine, cis-aconitic acid; phenylalanine, tyrosine, p-hydroxyphenylacetic acid, and homovanillic acid are all involved in the tyrosine pathway leading to neurotransmitter cathecolamine. Conclusion: GC-MS-based metabolomics analysis of the urinary metabolome seems to have the requested sensibility and specificity to get more insights of the ASD phenotypes and to propose for the disease a personalized network-based medicine.